(a) Cases and carriers affected with any of the following diseases and conditions of public health interest, and persons who at the time of their death were apparently so affected, shall be reported to the Department as specified in this article:
Alpha-gal syndrome, laboratory-confirmed (reporting requirement applicable to laboratories only)
Amebiasis
Anaplasmosis (Human granulocytic anaplasmosis)
Animal bite, or exposure to rabies
Anthrax
Arboviral infections, acute (including but not limited to the following viruses: chikungunya virus, Zika virus, dengue virus, Eastern equine encephalitis virus, Jamestown Canyon virus, Japanese encephalitis virus, La Crosse virus, Powassan virus, Rift Valley fever virus, St. Louis encephalitis virus, Western or Venezuelan equine encephalitis virus, West Nile virus and yellow fever)
Babesiosis
Blood lead level of three and a half micrograms per deciliter or higher (see also 24 RCNY Health Code § 11.09(a))
Botulism (including infant, foodborne and wound botulism)
Brucellosis (undulant fever)
Campylobacteriosis
Carbapenem-resistant organisms, laboratory-confirmed (reporting requirement applicable to laboratories only)
Chancroid
Chlamydia trachomatis infections
Cholera
Creutzfeldt-Jakob Disease
Cryptosporidiosis
Cyclosporiasis
Diphtheria
Drownings, defined as the process of experiencing respiratory impairment from submersion/immersion in liquid whether resulting in death or not
Ehrlichiosis (Human monocytic ehrlichiosis)
Encephalitis
Escherichia coli 0157:H7 infections
Falls from windows in multiple dwellings by children sixteen (16) years of age and under
Food poisoning occurring in a group of two or more individuals, including clusters of diarrhea or other gastrointestinal symptoms; or sore throat which appear to be due to exposure to the same consumption of spoiled, contaminated or poisonous food, or to having eaten at a common restaurant or other setting where such food was served. Also includes one or more suspected cases of neurologic symptoms consistent with foodborne toxin-mediated, including but not limited to botulism, combroid or ciguatera fish poisoning, or neurotoxic or paralytic shellfish poisoning.
Giardiasis
Glanders
Gonococcal infection (gonorrhea)
Granuloma inguinale
Hantavirus disease
Hemolytic uremic syndrome
Hemophilus influenzae (invasive disease)
Hepatitis A; B; and C
Herpes simplex virus, neonatal infections (in infants 60 days or younger)
Hospital associated infections as defined in Title 10 New York Codes, Rules and Regulations (NYCRR) Section 2.2 (New York State Sanitary Code) or its successor law, rule or regulation
Influenza, novel strain with pandemic potential
Influenza, laboratory-confirmed (reporting requirement applicable to laboratories only)
Influenza-related deaths of a child less than 18 years of age
Legionellosis
Leprosy
Leptospirosis
Listeriosis
Lyme disease
Lymphocytic choriomeningitis virus
Lymphogranuloma venereum
Malaria
Measles (rubeola)
Melioidosis
Meningitis, bacterial causes (specify type)
Meningococcal, invasive disease
Monkeypox
Mumps
Norovirus, laboratory-confirmed (reporting requirement applicable to laboratories only)
Pertussis (Whooping cough)
Plague
Poisoning by drugs or other toxic agents, including but not limited to carbon monoxide poisoning and/or a carboxyhemoglobin level above 10%; and including confirmed or suspected pesticide poisoning as demonstrated by:
(1) Clinical symptoms and signs consistent with a diagnosis of pesticide poisoning; or
(2) Clinical laboratory findings of blood cholinesterase levels below the normal range; or
(3) Clinical laboratory findings or pesticide levels in human tissue above the normal range.
Poliomyelitis
Psittacosis
Q fever
Rabies
Respiratory syncytial virus, laboratory-confirmed (reporting requirement applicable to laboratories only)
Ricin poisoning
Rickettsialpox
Rocky Mountain spotted fever
Rotavirus, laboratory-confirmed (reporting requirement applicable to laboratories only)
Rubella (German measles)
Rubella syndrome, congenital
Salmonellosis
Severe or novel coronavirus
Shiga toxin producing Escherichia coli (STEC) (which includes but is not limited to E. coli O157:H7)
Shigellosis
Smallpox (variola)
Staphylococcal enterotoxin B poisoning
Staphylococcus aureus, methicillin-resistant, laboratory-confirmed (reporting requirement applicable to laboratories only)
Staphylococcus aureus, vancomycin intermediate and resistant (VISA and VRSA)
Streptococcus, Group A (invasive infections)
Streptococcus, Group B (invasive infections)
Streptococcus pneumoniae invasive disease
Syphilis, all stages, including congenital
Tetanus
Toxic shock syndrome
Trachoma
Transmissible spongiform encephalopathy
Trichinosis
Tuberculosis, as demonstrated by:
(1) Positive culture for Mycobacterium tuberculosis complex; or
(2) Positive DNA probe, polymerase chain reaction (PCR), or other technique for identifying Mycobacterium tuberculosis from a clinical or pathology specimen; or
(3) Positive smear for acid-fast bacillus, with final culture results pending or not available, on either a microbacteriology or a pathology specimen; or
(4) Clinically suspected pulmonary or extrapulmonary (meningeal, bone, kidney, etc.) tuberculosis, such that the physician or other health care professional attending the patient has initiated or intends to isolate the patient or initiate treatment for tuberculosis, or to continue or resume treatment for previously incompletely treated disease, or, if the patient is not available, that the physician or other health care professional would initiate isolation or treatment if the patient were available; or
(5) Biopsy, pathology, or autopsy findings in lung, lymph nodes or other tissue specimens, consistent with active tuberculosis disease including, but not limited to presence of acid-fast bacilli, caseating and non-caseating granulomas, caseous matter, tubercles and fibro-caseous lesions; or
(6) Positive reaction to the tuberculin skin test administered using the Mantoux method, blood-based tests positive for tuberculosis infection, or other recognized diagnostic test positive for tuberculosis infection in a child less than five years of age, regardless of whether such child has had a BCG vaccination. This reporting requirement is applicable to healthcare providers only. The related reporting requirement for laboratories is set forth in paragraph (7) below.
(7) Blood-based test for tuberculosis infection, or other later developed diagnostic test for tuberculosis infection, for all persons regardless of age. This reporting requirement is applicable to laboratories only. The related reporting requirement for healthcare providers is set forth in paragraph (6) above.
Tularemia
Typhoid fever
Vaccinia disease, defined as
(1) Persons with vaccinia infection due to contact transmission; and
(2) Persons with the following complications from smallpox vaccination: eczema vaccinatum, erythema multiforme major or Stevens-Johnson syndrome, fetal vaccinia, generalized vaccinia, inadvertent inoculation, myocarditis or pericarditis, ocular vaccinia, post-vaccinial encephalitis or encephalomyelitis, progressive vaccinia, pyogenic infection of the vaccination site, and any other serious adverse events (i.e., those resulting in hospitalization, permanent disability, life-threatening illness or death)
Varicella, laboratory-confirmed (reporting requirement applicable to laboratories only)
Vibrio species, non-cholera (including parahaemolyticus and vulnificus)
Viral hemorrhagic fever
Yersiniosis
(b) (1) Suspected and confirmed cases or carriers of the following diseases or conditions of public health interest, and cases of persons who at the time of death were apparently so affected, shall be immediately reported to the Department by telephone and immediately in writing by submission of a report form via facsimile, mail or in an electronic transmission format acceptable to the Department, unless the Department determines that a written report is unnecessary.
Animal bites, from vector species at higher risk for rabies (including raccoons, skunks, foxes and bats) or any other animal with illness suggestive of rabies
Anthrax
Acute arboviral infections, as defined in subdivision (a) of this section (other than dengue)
Botulism
Brucellosis
Carbon monoxide poisoning
Cholera
Diphtheria
Food poisoning, as defined in subdivision (a) of this section
Glanders
Hantavirus
Hepatitis A in a food handler, or in an enrollee or attendee under the age of six or staff member who has contact with children under the age of six in a school, day care facility, camp or any other congregate setting with children under the age of six, or in a health care practitioner in a hospital or medical facility who provides oral care, or in an inmate of a correctional facility, or in a resident of a homeless facility or any other congregate residential setting
Influenza, novel strain with pandemic potential
Measles
Melioidosis
Meningococcal, invasive disease
Monkeypox
Plague
Poliomyelitis
Q fever
Rabies
Ricin
Rubella (German measles)
Severe or novel coronavirus
Smallpox
Staphylococcal enterotoxin B poisoning
Staphylococcus aureus, vancomycin intermediate and resistant (VISA and VRSA)
Tularemia
Vaccinia disease
Viral hemorrhagic fever
Any enteric disease (amebiasis, campylobacteriosis, cryptosporidiosis, E. coli 0157: H7 and other shiga toxin producing Escherichia coli (STEC) infections, giardiasis, salmonellosis, shigellosis, typhoid fever or yersiniosis) occurring in a food handler, or in an enrollee or attendee under the age of six or staff member who has contact with children under the age of six in a school, day care facility, camp or any other congregate setting with children under six, or in a health care practitioner in a hospital or medical facility who provides oral care, or in an inmate of a correctional facility, or in a resident of a homeless facility or any other congregate residential setting.
(2) All other diseases or conditions of public health interest that are required to be reported in subdivision (a) shall be reported to the Department within 24 hours of a diagnosis confirmed by laboratory or clinical criteria, by telephone, or in writing by submission of the appropriate Departmental report form via facsimile, mail or in an electronic transmission format acceptable to and approved by the Department.
(c) (1) An outbreak or suspected outbreak of any disease, condition of public health interest or syndrome of known or unknown etiology, that may be a danger to public health and occurs in three or more persons, or
(2) any unusual manifestation of a disease or condition of public health interest in an individual or
(3) an unusual disease defined as a newly apparent or emerging disease or a syndrome of uncertain etiology that could possibly be communicable, shall be reported to the Department immediately by telephone and in writing by submission of a report form via facsimile, mail or in an electronic transmission format acceptable to the Department within 24 hours after diagnosis unless the Department determines that a written report is unnecessary. An outbreak may be detected based on clinical, laboratory or epidemiologic evidence.
(d) Authority for syndromic surveillance. To ascertain the existence or monitor the progress of an outbreak, or the occurrence of unusual manifestations of disease, or of unusual diseases or conditions of public health interest, the Department may require reports by emergency departments, urgent care facilities, hospitals and clinics, and health information organizations which are comprised of such health care providers, as such terms are defined in Article 28 of the New York State Public Health Law or regulation promulgated thereunder, of all patient visits during each 24-hour period. Such reports shall be made electronically and in a form, manner and frequency as may be specified by the Department. Reports required by this subdivision may include age, gender, date and time of visit, ZIP code of residence, chief complaint, diagnosis or diagnosis code, disposition, radiographic results, laboratory results and a unique identification number adequate to access the patient's medical record if deemed necessary by the Department to investigate a suspected outbreak. In the event of a suspected or confirmed outbreak, and upon request by the Department, the identity of a patient shall be promptly reported to the Department.
(e) Information needed for investigations. Upon receipt of a report submitted pursuant to this section or any other provision of this article or other applicable law the Department may conduct such surveillance, epidemiologic and laboratory investigation activities as it shall deem necessary to verify the diagnosis, ascertain the source or cause of infection, injury or illness, identify additional cases, contacts, carriers or others at risk, and implement public health measures to control the disease or condition and prevent additional morbidity or mortality. Such investigations may include, but are not limited to, collecting or requiring collection of such clinical or environmental specimens for laboratory examination as the Department considers necessary, including the collection of specimens or isolates from clinical laboratories for testing by the Department or as designated by the Department. When deemed necessary for the protection of public health, in the course of conducting an investigation of a disease or condition made reportable to the Department by this article or other applicable law, the Department may require any person or any entity maintaining or managing health-related electronic records to provide reasonably necessary information including but not limited to information on household contact and non-household contact names and contact information, clinical signs and symptoms, treatment, including records of treatment, laboratory, radiological, or other diagnostic procedures as specified by the Commissioner or designee.
(Amended City Record 12/13/2016, eff. 1/12/2017; amended City Record 3/19/2018, eff. 4/18/2018; amended City Record 6/19/2019, eff. 7/19/2019; amended City Record 10/15/2019, eff. 11/14/2019; amended City Record 11/4/2022, eff. 12/4/2022; amended City Record 11/2/2023, eff. 12/2/2023)